Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-25 @ 1:14 AM
NCT ID: NCT03695393
Eligibility Criteria: Inclusion Criteria: * 18 years or older * HIV-positive * Current injection drug use (past 30 days) * Not currently on antiretroviral therapy (ART) * Provision of contact information for two contacts to assist with follow-up * Address within 100 kilometers of St. Petersburg * Possession of a telephone (home or cell) * Able and willing to comply with all study protocols and procedures over 6 months * Available at the specific days of the week and times that the group sessions will be occurring for the subsequent 3-4 weeks (to ensure that participants randomized into the intervention arm will be able to receive the intervention) Exclusion Criteria: * Not fluent in Russian * Cognitive impairment resulting in ability to provide informed consent based on research assessor (RA) assessment * Acute severe psychiatric illness (i.e., answered yes to any of the following: past three month active hallucinations; mental health symptoms prompting a visit to the Emergency Department (ED) or hospital; mental health medication changes due to worsening symptoms; presence of suicidal plans) and research assessor clinical observation (i.e. clinical observation or prior knowledge of severe personality disorder; past three months active mania; past three months active psychosis) * Enrolled in another research study * Participated in the pilot portion of the study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03695393
Study Brief:
Protocol Section: NCT03695393